Country: Իռլանդիա
language: անգլերեն
source: HPRA (Health Products Regulatory Authority)
Mepivacaine hydrochloride
Dechra Regulatory B.V.
QN01BB03
Mepivacaine hydrochloride
20 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
mepivacaine
Authorised
2006-12-01
Health Products Regulatory Authority 07 January 2019 CRN008S6T Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Intra-Epicaine 20 mg/ml solution for injection for horses 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Mepivacaine hydrochloride 20 mg For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear, colourless mobile liquid, practically free from visible particles. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Mepivacaine is indicated for infiltration, nerve block, intra-articular and epidural anaesthesia in horses. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Care should be taken to avoid intra-vascular injection by aspiration prior to and during administration. Health Products Regulatory Authority 07 January 2019 CRN008S6T Page 2 of 5 The analgesic effect of mepivacaine, when used as part of a lameness investigation, begins to subside after 45 – 60 minutes. However, sufficient analgesia may persist to affect gait beyond two hours. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Care should be taken to avoid accidental self injection or skin contact. In the event of accidental self-injection medical advice should be sought. Wash splashes from skin and eyes immediately. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Transient, local soft tissue swelling may occur in a small proportion of cases following injection of the product. Local anaesthetics used in excess can cause systemic toxicity characterised by CNS effects. If systemic toxicity occurs, as a result of inadvertent intra-vascular injection, the administration of oxygen to treat cardio-respiratory depression and diazepam to control convulsions should be considered. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Not cont read_full_document